These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31616542)

  • 1. Induction of differentiation of human stem cells
    Lei XH; Yang YQ; Ma CY; Duan EK
    World J Stem Cells; 2019 Sep; 11(9):666-676. PubMed ID: 31616542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet bioreactor: accelerated evolution of design and manufacture.
    Thon JN; Dykstra BJ; Beaulieu LM
    Platelets; 2017 Jul; 28(5):472-477. PubMed ID: 28112988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulating megakaryocytes to manufacture platelets ex vivo.
    Karagiannis P; Eto K
    J Thromb Haemost; 2015 Jun; 13 Suppl 1(Suppl 1):S47-53. PubMed ID: 26149050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Biophysical and Biochemical Signals Augment Megakaryopoiesis and Thrombopoiesis in a Three-Dimensional Rotary Culture System.
    Yang Y; Liu C; Lei X; Wang H; Su P; Ru Y; Ruan X; Duan E; Feng S; Han M; Xu Y; Shi L; Jiang E; Zhou J
    Stem Cells Transl Med; 2016 Feb; 5(2):175-85. PubMed ID: 26702125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro generation of platelets: Where do we stand?
    Di Buduo CA; Kaplan DL; Balduini A
    Transfus Clin Biol; 2017 Sep; 24(3):273-276. PubMed ID: 28669522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-platelets.
    Chen SJ; Sugimoto N; Eto K
    Int J Hematol; 2023 Mar; 117(3):349-355. PubMed ID: 36574167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards the Manufacture of Megakaryocytes and Platelets for Clinical Application.
    Baigger A; Blasczyk R; Figueiredo C
    Transfus Med Hemother; 2017 Jun; 44(3):165-173. PubMed ID: 28626367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production.
    Ito Y; Nakamura S; Sugimoto N; Shigemori T; Kato Y; Ohno M; Sakuma S; Ito K; Kumon H; Hirose H; Okamoto H; Nogawa M; Iwasaki M; Kihara S; Fujio K; Matsumoto T; Higashi N; Hashimoto K; Sawaguchi A; Harimoto KI; Nakagawa M; Yamamoto T; Handa M; Watanabe N; Nishi E; Arai F; Nishimura S; Eto K
    Cell; 2018 Jul; 174(3):636-648.e18. PubMed ID: 30017246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ex vivo platelet production from induced pluripotent stem cells].
    Sugimoto N; Eto K
    Rinsho Ketsueki; 2018; 59(10):1905-1913. PubMed ID: 30305491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whirling Platelets Away for Transfusion.
    Iancu-Rubin C; Hoffman R; Migliaccio AR
    Cell; 2018 Jul; 174(3):503-504. PubMed ID: 30053423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mimicking megakaryopoiesis in vitro using biomaterials: Recent advances and future opportunities.
    Ingavle G; Shabrani N; Vaidya A; Kale V
    Acta Biomater; 2019 Sep; 96():99-110. PubMed ID: 31319203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel bioreactor and culture method drives high yields of platelets from stem cells.
    Avanzi MP; Oluwadara OE; Cushing MM; Mitchell ML; Fischer S; Mitchell WB
    Transfusion; 2016 Jan; 56(1):170-8. PubMed ID: 26467770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A uniform-shear rate microfluidic bioreactor for real-time study of proplatelet formation and rapidly-released platelets.
    Martinez AF; McMahon RD; Horner M; Miller WM
    Biotechnol Prog; 2017 Nov; 33(6):1614-1629. PubMed ID: 28960897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNAs can increase the efficiency of ex vivo platelet generation.
    Emmrich S; Henke K; Hegermann J; Ochs M; Reinhardt D; Klusmann JH
    Ann Hematol; 2012 Nov; 91(11):1673-84. PubMed ID: 22763947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational approaches to functional platelet production ex vivo.
    Balduini A; Di Buduo CA; Kaplan DL
    Thromb Haemost; 2016 Jan; 115(2):250-6. PubMed ID: 26353819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Inhibition of ADAM17 Efficiently Mediates Glycoprotein Ibα Retention During Ex Vivo Generation of Human Induced Pluripotent Stem Cell-Derived Platelets.
    Hirata S; Murata T; Suzuki D; Nakamura S; Jono-Ohnishi R; Hirose H; Sawaguchi A; Nishimura S; Sugimoto N; Eto K
    Stem Cells Transl Med; 2017 Mar; 6(3):720-730. PubMed ID: 28297575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in ex vivo platelet production.
    Nurhayati RW; Ojima Y; Taya M
    Cytotechnology; 2016 Dec; 68(6):2211-2221. PubMed ID: 27002966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel platelet pharming using human induced pluripotent stem cells].
    Flahou C; Sugimoto N; Eto K
    Bull Acad Natl Med; 2020 Dec; 204(9):961-970. PubMed ID: 33012790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro-derived platelets: the challenges we will have to face to assess quality and safety.
    Mookerjee S; Foster HR; Waller AK; Ghevaert CJ
    Platelets; 2020 Aug; 31(6):724-730. PubMed ID: 32486997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes.
    Nakagawa Y; Nakamura S; Nakajima M; Endo H; Dohda T; Takayama N; Nakauchi H; Arai F; Fukuda T; Eto K
    Exp Hematol; 2013 Aug; 41(8):742-8. PubMed ID: 23618622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.